ArticlePharmaceutics2022

Glioblastoma Multiforme Selective Nanomedicines for Improved Anti-Cancer Treatments.

Jason Thomas Duskey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.